Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study
Authors:
Top Cited Papers
Open Access
- 2 July 2025
- journal article
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 142, 152619
Abstract
No abstract availableKeywords
Funding Information
- Imperial College London (COMP360)
This publication has 45 references indexed in Scilit:
- Adverse Events in Studies of Classic PsychedelicsJAMA Psychiatry, 2024
- Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA, 2023
- Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implicationsComprehensive Psychiatry, 2022
- Suicidality in patients with obsessive-compulsive and related disorders (OCRDs): A meta-analysisComprehensive Psychiatry, 2021
- Psychedelic Psychiatry’s Brave New WorldCell, 2020
- A Randomized Trial Directly Comparing Ventral Capsule and Anteromedial Subthalamic Nucleus Stimulation in Obsessive-Compulsive Disorder: Clinical and Imaging Evidence for Dissociable EffectsBiological Psychiatry, 2019
- Psilocybin with psychological support improves emotional face recognition in treatment-resistant depressionPsychopharmacology, 2017
- Incompleteness and harm avoidance in OCD symptom dimensionsBehaviour Research and Therapy, 2008
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significancePsychopharmacology, 2006
- The Yale-Brown Obsessive Compulsive ScaleArchives of General Psychiatry, 1989